Evolent Health, Inc. (EVH) Stock
EVH Key Statistics
About Evolent Health, Inc.
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
CEO: Seth Barrie Blackley. Company website
EVH — Frequently Asked Questions
What is the EVH stock price today?
Evolent Health, Inc. (EVH) trades at $3.69, up 0.54% on the day, as of Sep 20, 2026 15:00 UTC.
What is Evolent Health, Inc.'s market cap?
Evolent Health, Inc. has a market capitalisation of $415.06M, calculated from the live EVH share price and shares outstanding.
What is the P/E ratio of EVH?
EVH has no meaningful price-to-earnings ratio: Evolent Health, Inc. lost $4.49 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Evolent Health, Inc. make?
Evolent Health, Inc. generated revenue of $2.10B over the trailing twelve months, which puts the stock at 0.20 times sales.
What is the 52-week range for EVH?
EVH has traded between $2.10 and $9.63 over the past 52 weeks, and the last price is 61.7% below that high.
Is Evolent Health, Inc. profitable?
No. Evolent Health, Inc. is loss-making, with a net margin of -24.08% over the trailing twelve months.
What is the analyst price target for EVH?
Wall Street analysts rate EVH Buy, with an average price target of $7.00, 89.7% above the current price.
What sector is Evolent Health, Inc. in?
Evolent Health, Inc. is classified under the Healthcare sector and the Medical - Healthcare Information Services industry, and is domiciled in US.
Who is the CEO of Evolent Health, Inc.?
Seth Barrie Blackley is the chief executive of Evolent Health, Inc., which employs 4,200 people.
Where can I track EVH in real time?
QFI Terminal shows EVH with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See EVH live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open EVH in Terminal See plans